Akcea Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AKCA and buy or sell other stocks, ETFs, and their options commission-free!

About AKCA

Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. 

CEO
Damien McDevitt, PhD
CEODamien McDevitt, PhD
Employees
—
Employees—
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
—
Employees—

AKCA Key Statistics

Market cap
1.85B
Market cap1.85B
Price-Earnings ratio
-46.08
Price-Earnings ratio-46.08
Dividend yield
—
Dividend yield—
Average volume
476.70K
Average volume476.70K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$21.71
52 Week high$21.71
52 Week low
$8.00
52 Week low$8.00

People also own

Based on the portfolios of people who own AKCA. This list is generated using Robinhood data, and it’s not a recommendation.
Inovio
Aurora Cannabis
Cronos Group
CRISPR
Micron Technology
Viking Therapeutics
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.